Government policy and the rate of immunity will determine how quickly coronavirus settles into a ‘predictable endemic state’, advisers say
At least 17 people suspected of having the Omicron variant of coronavirus after a ‘super spreader’ Christmas party in Oslo were fully vaccinated, city health officials have said.
More than 100 cases of new variant have now been found in England; Strict social distancing will be required in Ireland’s bars and restaurants with mandatory table service and a maximum of six people per table.
As of this morning, British drug regulators have approved the Covid-19 antiviral drug molnupiravir for use in Covid-19 patients at risk for severe illness, making them the first public health officials to do so.
Scientists from the University of Bristol and start-up Halo Therapeutics are developing antiviral treatments that could prevent the virus from entering the body. The team recently reported a breakthrough discovery in Science magazine. They found that exposing SARS-CoV-2 to linoleic acid locks the virus’s spike protein into a closed shape. This: blocks the virus’s entry […]
Taking the long view fighting COVID-19 While the world has been focused on a vaccine, Professor Imre Berger is taking the long view on coronavirus, by exploring how best to treat the virus as an ongoing problem
Forget Boris Johnson’s anti-Covid pills… scientists are now pinning their hopes on a nasal spray to reduce the severity of the disease and help stop its spread
It’s an attractive prospect: a single pill, popped immediately after you test positive for Covid, to stop the virus in its tracks and prevent serious disease.
Since the novel SARS-CoV-2 coronavirus changed everyone’s lives in March 2020, an extraordinary amount of time and effort has gone into understanding and characterizing this virus.
While the world has been focused on a vaccine, Professor Imre Berger is taking the long view on coronavirus, by exploring how best to treat the virus as an ongoing problem, including targeting ‘hot zones’.
A team of top scientists from the University of Bristol have announced the formation of a new biotech company that is developing newly patented potential treatments for Coronavirus.